Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes » Emergencies
Health Care [N] » Environment and Public Health [N06] » Environment » Disasters » Emergencies
Health Care [N] » Environment and Public Health [N06] » Public Health » Emergencies
Description
Situations or conditions requiring immediate intervention to avoid serious adverse results. MeSH
Hierarchy View
Phase 4 Indicated Drugs (14)
Phase 3 Indicated Drugs (4)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (132)
Al- Elweyia Maternity Teaching Hospital
Canadian Institutes of Health Research (CIHR)
Cantonal Hospital of St. Gallen
Centre Hospitalier Universitaire de la Réunion
Centre Hospitalier Universitaire de Nīmes
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Health Research Board, Ireland
Hoosier Cancer Research Network
Icahn School of Medicine at Mount Sinai
Katholieke Universiteit Leuven
Kecioren Education and Training Hospital
Lakeland Regional Medical Center
Mater Misericordiae University Hospital
Medical Research Foundation, Oregon
MercyOne Des Moines Medical Center
Methodist Cancer Center, Houston, Texas
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institutes of Health (NIH)
National University of Ireland
Oregon Health and Science University
People's Liberation Army of China
Royal College of Surgeons, Ireland
The University of Texas, Dallas
Organization Involved with Phase 3 Indications (64)
Assistance Publique - Hôpitaux de Paris
Autonomous University of Madrid
Centre Hospitalier de la Région d'Annecy
Children's National Medical Center
Chinese People's Armed Police Forces
Commonwealth Scientific and Industrial Research Organisation, Australia
General Hospital of Chinese Armed Police Forces
Hellenic Institute for the Study of Sepsis
Hôpitaux Pédiatriques de Nice CHU-LENVAL
Institut National de la Santé Et de la Recherche Médicale, France
Nanjing Yoko Biomedical Co., Ltd.
National Institute of Allergy and Infectious Diseases (NIAID)
New York Presbyterian Hospital
Spanish Clinical Research Network
Spanish Society for Emergency Medicine (SEMES)
The Family Planning Association of Hong Kong
The Physicians' Services Incorporated Foundation
Organization Involved with Phase 2 Indications (20)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (46)
American College of Emergency Physicians
Arizona College of Emergency Physicians
Derince Training and Research Hospital
District of Columbia Department of Health
Eastern Virginia Medical School
Federal University of the Valleys of Jequitinhonha and Mucuri
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
National Center for Research Resources (NCRR)
National Institute of Nursing Research (NINR)
Salient Pharmaceuticals Incorporated
State University of New York, Buffalo
The Royal Bournemouth Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.